SHANGHAI, May 28, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results